Filter
1264
Filtered Results: 1264
Text search:
Health
Care
Without
Harm
Asia
Featured
Recommendations
141
New Publications
266
Language
Document type
No document type
665
Studies & Reports
239
Guidelines
202
Manuals
76
Strategic & Response Plan
37
Training Material
24
Fact sheets
9
Situation Updates
6
Infographics
4
Resource Platforms
1
Online Courses
1
Countries / Regions
Global
84
Western and Central Europe
39
India
37
Myanmar / Burma
29
Ukraine
22
Asia
20
South–East Asia Region
20
Bangladesh
16
Nepal
15
Philippines
15
Indonesia
13
Latin America and the Carribbean
12
Eastern Europe
12
Syria
11
Eastern Europe and Central Asia
11
Nigeria
10
Ethiopia
9
Kenya
8
Afghanistan
8
Cambodia
8
Middle East and North Africa
8
Russia
8
Africa
7
Tanzania
7
West and Central Africa
7
South Africa
7
Uganda
7
Zambia
7
Pakistan
7
Tajikistan
6
Thailand
6
Western Pacific Region
6
East and Southern Africa
6
Vietnam
6
Liberia
6
Namibia
4
Georgia
4
Ghana
3
Sierra Leone
3
China
3
Iran
3
Laos
3
Zimbabwe
3
Congo, Democratic Republic of
3
Yemen
3
South Sudan
3
North Macedonia
2
Albania
2
Kyrgyzstan
2
Malawi
2
Malaysia
2
Guinea
2
USA
2
Croatia
2
Japan
2
Moldova
2
Somalia
2
Colombia
1
Mexico
1
Serbia
1
Lesotho
1
Turkey
1
Rwanda
1
Kazakhstan
1
Canada
1
Singapore
1
Senegal
1
Uzbekistan
1
Qatar
1
Italy
1
Armenia
1
Haiti
1
Venezuela
1
Lithuania
1
Jordan
1
North America
1
Turkmenistan
1
United Kingdom
1
Portugal
1
Spain
1
Azerbaijan
1
Bosnia and Herzegovina
1
Papua New Guinea
1
Brazil
1
Sri Lanka
1
Central African Republic
1
Libya
1
Botswana
1
Iraq
1
Ecuador
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
211
Clinical Guidelines
125
Women & Child Health
122
Key Resources
91
Public Health
90
Capacity Building
22
Pharmacy & Technologies
12
Toolboxes
HIV
237
Mental Health
178
COVID-19
91
Planetary Health
66
TB
49
Refugee
42
Global Health Education
40
Disability
35
Caregiver
34
Conflict
33
Rapid Response
23
AMR
23
Pharmacy
19
NTDs
18
Health Financing Toolbox
17
NCDs
17
Specific Hazards
14
Natural Hazards
14
2.0 Rapid Response
14
Ebola & Marburg
11
Malaria
11
Zika
7
Polio
6
Social Ethics
5
Cholera
4
Toolkit regarding Zika Virus
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Q4: Should community based rehabilitation be offered to children with intellectual disabilities?
Humanitarian emergencies, regardless of type and cause, have a number of common risk factors for communicable diseases inextricably linked to excess risk of morbidity and mortality which can come from vaccine–preventable diseases (VPDs). The reduction of VPDs is a significant aim of public-health ...
The Western Pacific Regional Action Plan for the Prevention and Control of Noncommunicable Diseases (2014–2020) was developed in response to a resolution adopted at the sixty-second session of the WHO Regional Committee for the Western Pacific. The regional plan is fully harmonized with...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
Management of Snake Bite. Quick Reference Guide
recommended
Standard Treatment Guideline
The World Health Organization (WHO) has identified mental health as an integral component of the COVID-19 response. Its rapid assessment of service delivery for mental, neurological and substance use (MNS) disorders during the COVID-19 pandemic, on which this report is based, is the first attempt to...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), helps national and local stakeholders to design country-specific social and behavioural change communication (SBCC) campaigns that address the threat posed by substandard, spurious, falsified and fal...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
This publication provides guidance for planning country-specific programming to achieve the triple elimination of mother-to-child (or vertical) transmission of HIV, syphilis and hepatitis B virus. It is based on the WHO Triple Elimination Framework, which promotes an integrated, person-centred appro...
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages...
WHO consolidated guidelines on tuberculosis: Module 6: tuberculosis and comorbidities, 2nd ed
recommended
Addressing TB comorbidities and risk factors is central to the World Health Organization (WHO) End TB Strategy. These guidelines consolidate the latest WHO recommendations on TB and key comorbidities. The guidelines are a living document and will include dedicated sections for each key TB comorbidit...
This guidance document has been produced by WHO to assist blood services in the development of national plans to respond to any emerging infectious threats to the sufficiency or safety of the blood supply, whether from an existing infectious agent that is changing in incidence and spread, or from a ...
Breast cancer is the most common cancer worldwide and the leading cause of cancer deaths among women, disproportionately affecting low- and middle-income countries. The Global Breast Cancer Initiative strives to reduce breast cancer mortality by 2.5 percent per year, which over a 20-year period can ...
